Eyewire Today

Advertisement

Archives: Glaucoma

Show articles per page

Thursday, April 10, 2014

Studying Glucocorticoid-Induced Glaucoma in Murine Model

From Medical News Today

Patients with inflammatory diseases, including allergy, asthma, and autoimmune disorders are often prescribed glucocorticoids; however, a subset of patients develop secondary glaucoma in response to treatment and must st... Read full article

Tuesday, April 01, 2014

U.S. Top Court Declines to Hear Patent Case on Glaucoma Drug

From Reuters

The U.S. Supreme Court on Monday left intact an appeals court ruling that endorsed patent protections for Combigan, Allergan Inc's glaucoma drug. The high court declined to hear an appeal filed by Novartis AG's Sandoz In... Read full article

Monday, March 31, 2014

BioLight Announces IND Filing with FDA for Phase 1/2a Clinical Study of its...

From BioLight Israeli Life Sciences Invest...

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned s... Read full article

Monday, March 24, 2014

OcuTherix Developing CU Next-Generation Glaucoma Treatment

From University of Colorado

OcuTherix, Inc. and the University of Colorado (CU) have completed an exclusive license that will allow the company to continue developing a new non-invasive procedure for the treatment of glaucoma that uses patent-pendi... Read full article

Friday, March 14, 2014

Is Glaucoma, In Fact, Diabetes of the Brain?

From Medical News Today

Researchers at All India Institute of Medical Sciences and Ambedkar Centre for Biomedical Research India have proposed a new mechanism of glaucoma which suggests that diabetes can occur in the brain and may be the cause ... Read full article

Thursday, March 06, 2014

Visual Field Index Overlooks Neural Loss in Early Glaucoma

From Medscape Ophthalmology

The visual field index underestimates the amount of neural loss in eyes affected by glaucoma, particularly in early disease, a new study suggests. "In early disease, we should rely less on the visual field index," said A... Read full article

Tuesday, March 04, 2014

Glaucoma Shunt Comparison Yields Key Differences at 5 Years

From Medscape Ophthalmology

For patients with refractory glaucoma, success rates are similar with the Ahmed glaucoma valve and the Baerveldt implant, but new 5-year results show that intraocular pressure is higher with the Ahmed device and may resu... Read full article

Tuesday, February 25, 2014

Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechani...

From Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc. announced the results of preclinical in vivo research demonstrating the ability of AR-13324 to reduce episcleral venous pressure (EVP) in the eye, according to a company news release. AR-13324... Read full article

Friday, February 21, 2014

Glucose Prompts Passing Glaucoma Fix in Some

From Medscape Ophthalmology

In patients with primary open-angle glaucoma (POAG), topical application of glucose can lead to temporary recovery, according to Australian researchers. Dr. Robert J. Casson told Reuters Health by email, "Our findings in... Read full article

Monday, February 17, 2014

New Eye Layer has Possible Link to Glaucoma

From MedicalXpress

A new layer in the human cornea, discovered by researchers at The University of Nottingham last year, plays a vital role in the structure of the tissue that controls the flow of fluid from the eye, research has shown. Th... Read full article

Friday, February 14, 2014

Nanodiamond-Embedded Contact Lenses May Improve Glaucoma Treatment

From Health News Digest

By 2020, nearly 80 million people are expected to have glaucoma, a disorder of the eye that, if left untreated, can damage the optic nerve and eventually lead to blindness. The disease often causes pressure in the eye du... Read full article

Friday, February 07, 2014

Effectiveness of Glaucoma Drugs Similar in Trials and 'Real Life'

From Medscape Ophthalmology

Eye drops to lower intraocular pressure are as effective in real-life use as they are among clinical trial subjects, a new study suggests. The study is important because it clarifies the actual effect of these drugs for ... Read full article

Tuesday, February 04, 2014

InnFocus, Inc. To Present Compelling Clinical Results At The Glaucoma 360 N...

From InnFocus, Inc.

InnFocus, Inc., announced that it will participate in the Glaucoma 360 New Horizons Forum on Friday, February 7th, 2014 at The Palace Hotel, in San Francisco. The event is presented by the Glaucoma Research Foundation an... Read full article

Monday, February 03, 2014

Postmenopausal Estrogen May Slightly Lower Risk for Glaucoma

From Medscape Ophthalmology

Use of postmenopausal hormones containing estrogen may reduce the risk for primary open-angle glaucoma, according to a report published online January 30 in JAMA Ophthalmology. Several lines of evidence point to a role f... Read full article

Friday, January 31, 2014

Potential Drug Targets Found for Early Onset Glaucoma

From Medical News Today

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma. Glauc... Read full article

Thursday, January 30, 2014

Aerie Pharmaceuticals Initiates Phase 2b Study of PG324, a Novel Fixed-Comb...

From Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals Inc. announced dosing of the first patients enrolled in the companys Phase 2b study of PG324, a novel, fixed-combination of Aeries AR-13324 and latanoprost, a prostaglandin analogue that is the most... Read full article

Tuesday, January 21, 2014

Probability of Blindness From Glaucoma Has Nearly Halved

From American Academy of Ophthalmology

The probability of blindness due to glaucoma has decreased by nearly half since 1980, according to a study published this month in Ophthalmology. The researchers speculate that advances in diagnosis and therapy are likel... Read full article

Tuesday, January 14, 2014

Pilot Study for the First Implantable, Permanent Intraocular Pressure Senso...

From Medical News Today

Implandata Ophthalmic Products GmbH has successfully completed its ARGOS-01 pilot study for the first implantable, permanent intraocular pressure sensor. Implant safety and functionality has been demonstrated in this stu... Read full article

Monday, January 13, 2014

Sleeping on One Side May Worsen Glaucoma: Study

From Medscape Ophthalmology

In a new study from South Korea, people with worsening glaucoma on just one side were also more likely to sleep with the affected eye facing downward. The researchers say that position raises the eye's internal pressure ... Read full article

Thursday, January 09, 2014

Aerie Pharmaceuticals Reports Positive Results for Lead Candidate AR-13324 ...

From Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals, Inc., announced top-line results from the company's recently completed phase 1 pharmacokinetics (PK) study, in which AR-13324 eye drops were administered once-daily to 18 healthy individuals over a... Read full article

Advertisement

Featured Jobs
  • General Ophthalmologist

    , FL (Statewide)

    Established over 60 years ago, one of Floridas busiest and most respected practices is seeking an experience general ophthalmologist. Ideal candidate will have an interest and experience in glaucoma or light plastics as ...